More importantly, CIP2A overexpression has been detected in a broad range of malignancies, including hepatocellular carcinoma (HCC) [111] and bladder carcinoma, in which its expression correlates with disease progression [112]. The gene discussed is CIP2A; the disease is hepatocellular carcinoma.